CVS Health Corp (CVS-N) Stock Predictions - Stockchase
WATCH LIST
179
CVS Health Corp (CVS-N)

ON STOCKCHASE SINCE Dec 2001

retail drug store chain

specialty stores

CVS Health Corp CVS Health Corp
CVS-N

41 179
specialty stores

CVS Health Corp (CVS-N) SAVE

73.2

1.56 (2.18%)

Aug, 17, 2018, 12:00 am

OPINIONS

About CVS Health Corp (CVS-N)

CVS Health is an American retail pharmacy and health care company headquartered in Woonsocket, Rhode Island. More at Wikipedia

What the experts are saying about CVS-N



  • All
  • Filtered
Signal Opinion Expert
WAIT
CVS Health Corp(CVS-N) 

August 8, 2018

She has owned this for a number of years.  They operate a large pharmacy stores.  They are buying a health insurance company.  Amazon may be a threat but CVS have their own direct delivery service.  They reported today and had a good quarter.  This industry is evolving and have to monitor it closely.  They are well positioned to compete.

specialty stores

She has owned this for a number of years.  They operate a large pharmacy stores.  They are buying a health insurance company.  Amazon may be a threat but CVS have their own direct delivery service.  They reported today and had a good quarter.  This industry is evolving and have to monitor it closely.  They are well positioned to compete.

specialty stores
Christine Poole

CEO & Mana, GlobeInvest Capital ...

Price Price
$68.170
Owned Owned
Yes

SELL
CVS Health Corp(CVS-N) 

August 7, 2018

He is negative on the space of drug distributors and pharmacy benefits managers. He thinks that policy pressures and pricing pressures make the PBM side of CVS a bad investment. The unrelenting pressure is driving more business to United Health, which is very efficient. Going top down: He doesn’t like consumer staples at this time and within that he doesn’t like distributors, and within that is all the difficulty in distribution of pharma. He thinks they’ve make good strides improving the retail, but the back end will be very tough for a long time. He would recommend cutting losses for someone who owns this and investing in medical devices or in a more general healthcare ETF. (Analysts’ price target is $85.47)

specialty stores

He is negative on the space of drug distributors and pharmacy benefits managers. He thinks that policy pressures and pricing pressures make the PBM side of CVS a bad investment. The unrelenting pressure is driving more business to United Health, which is very efficient. Going top down: He doesn’t like consumer staples at this time and within that he doesn’t like distributors, and within that is all the difficulty in distribution of pharma. He thinks they’ve make good strides improving the retail, but the back end will be very tough for a long time. He would recommend cutting losses for someone who owns this and investing in medical devices or in a more general healthcare ETF. (Analysts’ price target is $85.47)

specialty stores
Cameron Hurst

Chief Inve, Equium Capital Manag...

Price Price
$65.450
Owned Owned
No

BUY on WEAKNESS
CVS Health Corp(CVS-N) 

August 1, 2018

They are one of the largest pharma distributor in the US.  Their recent acquisition is a plan to position the company in health management – helping companies send orders to pharmacies.  The company is one they are looking into.  The stock is trading at a reasonable valuation and it generates good cash flow.  The debt load is not onerous.  They are here to stay.  (Analysts’ price target is $86)  

specialty stores

They are one of the largest pharma distributor in the US.  Their recent acquisition is a plan to position the company in health management – helping companies send orders to pharmacies.  The company is one they are looking into.  The stock is trading at a reasonable valuation and it generates good cash flow.  The debt load is not onerous.  They are here to stay.  (Analysts’ price target is $86)  

specialty stores
Lorne Steinberg

President , Lorne Steinberg Weal...

Price Price
$64.090
Owned Owned
No

STRONG BUY
CVS Health Corp(CVS-N) 

July 27, 2018

He has been recommending this for a while, buying a company at less than 9 times earnings.  A really good business at a discounted price right now.  The headwinds of the headline risk against pharma has played out.  A strong buy for the next 5 years investment horizon.  

specialty stores

He has been recommending this for a while, buying a company at less than 9 times earnings.  A really good business at a discounted price right now.  The headwinds of the headline risk against pharma has played out.  A strong buy for the next 5 years investment horizon.  

specialty stores
Bryden Teich

Portfolio , Avenue Investment Ma...

Price Price
$66.670
Owned Owned
Yes

PAST TOP PICK
CVS Health Corp(CVS-N) 

July 20, 2018

(A Top Pick May 1/17 - Down 19%) Still like it. A health company that went through a vertical integration buying Aetna. Not expensive on a cash flow basis. Amazon.com Inc. (AMZN-O) purchase of Pill Pack affected the stock. 

specialty stores

(A Top Pick May 1/17 - Down 19%) Still like it. A health company that went through a vertical integration buying Aetna. Not expensive on a cash flow basis. Amazon.com Inc. (AMZN-O) purchase of Pill Pack affected the stock. 

specialty stores
Paul Harris, CF

Portfolio , Avenue Investment Ma...

Price Price
$66.140
Owned Owned
Yes

COMMENT
CVS Health Corp(CVS-N) 

July 5, 2018

Shorter term the fact that Amazon said it is entering the space affects sentiment. He still doesn’t like the retail noise. He prefers United Health Group (UNH-N). (Analysts’ price target is $85.40)

specialty stores

Shorter term the fact that Amazon said it is entering the space affects sentiment. He still doesn’t like the retail noise. He prefers United Health Group (UNH-N). (Analysts’ price target is $85.40)

specialty stores
Paul Macdonald

Chief Inve, Harvest Portfolios G...

Price Price
$65.090
Owned Owned
No

WATCH
CVS Health Corp(CVS-N) 

June 29, 2018

Amazon is trying to work their way into the health industry and this is directly impacting this company.  We don’t know how it will impact CVS in the long term, but the short term fear is creating headwinds.  Overall, a good business, but he would wait to see what happens.  

specialty stores

Amazon is trying to work their way into the health industry and this is directly impacting this company.  We don’t know how it will impact CVS in the long term, but the short term fear is creating headwinds.  Overall, a good business, but he would wait to see what happens.  

specialty stores
Chris Stuchberr

Portfolio , Wellington-Altus Pri...

Price Price
$64.350
Owned Owned
No

BUY on WEAKNESS
CVS Health Corp(CVS-N) 

June 26, 2018

Model price is $83.03. The stock is at $70.50 today. CVS bottomed out. He expects the high to be about $87. However, any time Amazon can announce again that it is going into the pharma business, CVS will drop. Its downside risk is about $63.60 and he would buy at that price. (Analysts’ price target is $50.41)

specialty stores

Model price is $83.03. The stock is at $70.50 today. CVS bottomed out. He expects the high to be about $87. However, any time Amazon can announce again that it is going into the pharma business, CVS will drop. Its downside risk is about $63.60 and he would buy at that price. (Analysts’ price target is $50.41)

specialty stores
Brian Acker, CA

Chief Exec, Acker Finley Inc....

Price Price
$69.810
Owned Owned
Yes

BUY
CVS Health Corp(CVS-N) 

June 25, 2018

He bought some this year.  The first time in a while.  It is cheap.  They are trying to diversify across verticals.  Their acquisition needs approval so the stock is stuck.

specialty stores

He bought some this year.  The first time in a while.  It is cheap.  They are trying to diversify across verticals.  Their acquisition needs approval so the stock is stuck.

specialty stores
Robert Lauzon

Deputy Chi, Middlefield Capital ...

Price Price
$71.430
Owned Owned
Yes

BUY
CVS Health Corp(CVS-N) 

June 25, 2018

He bought some this year.  The first time in a while.  It is cheap.  They are trying to diversify across verticals.  Their acquisition needs approval so the stock is stuck.

specialty stores

He bought some this year.  The first time in a while.  It is cheap.  They are trying to diversify across verticals.  Their acquisition needs approval so the stock is stuck.

specialty stores
Robert Lauzon

Deputy Chi, Middlefield Capital ...

Price Price
$71.430
Owned Owned
Yes

PAST TOP PICK
CVS Health Corp(CVS-N) 

June 7, 2018

(A Top Pick Jun. 21'17, Down 14%)  It is an interesting space.  They are seeing a changing dynamic in healthcare.  They are acquiring another company.  Their vision is to control the patient experience.  They want to provide more health care than just filling a prescription.  Most healthcare service is the monitoring of chronic conditions.  They should bring healthcare costs down.  This is an area where the market has not rewarded them.

specialty stores

(A Top Pick Jun. 21'17, Down 14%)  It is an interesting space.  They are seeing a changing dynamic in healthcare.  They are acquiring another company.  Their vision is to control the patient experience.  They want to provide more health care than just filling a prescription.  Most healthcare service is the monitoring of chronic conditions.  They should bring healthcare costs down.  This is an area where the market has not rewarded them.

specialty stores
Gordon Reid

President, GoodReid Investment ...

Price Price
$65.020
Owned Owned
Yes

PAST TOP PICK
CVS Health Corp(CVS-N) 

June 7, 2018

(Past Top Pick on April 13, 2017, Down 14%) Still likes it. It's more than the Shoppers Drug Mart of the US--it's a healthcare company. Trading at 9x earnings, good free cash flow. Their Aetna deal with work out.

specialty stores

(Past Top Pick on April 13, 2017, Down 14%) Still likes it. It's more than the Shoppers Drug Mart of the US--it's a healthcare company. Trading at 9x earnings, good free cash flow. Their Aetna deal with work out.

specialty stores
Paul Harris, CF

Portfolio , Avenue Investment Ma...

Price Price
$65.020
Owned Owned
Yes

TOP PICK
CVS Health Corp(CVS-N) 

June 7, 2018

Trading at 9x earnings and paying a 3.1% dividend. The success of their large Aetna purchase (which still needs approval) will depend on how well CVS integrates it, which is risky. CVS is about integration: long-term care, pharmacy and home fusion. This integration can propel higher margins. (Analysts' price target: $86.81)

specialty stores

Trading at 9x earnings and paying a 3.1% dividend. The success of their large Aetna purchase (which still needs approval) will depend on how well CVS integrates it, which is risky. CVS is about integration: long-term care, pharmacy and home fusion. This integration can propel higher margins. (Analysts' price target: $86.81)

specialty stores
Paul Harris, CF

Portfolio , Avenue Investment Ma...

Price Price
$65.020
Owned Owned
Yes

DON'T BUY
CVS Health Corp(CVS-N) 

June 5, 2018

A healthcare stock that pays a decent dividend is a popular hiding place, but this trade got really crowded. CVS got into a down channel. Wait until everybody has sold till you start buying. He's worried that investors are still buying and
analysts are still recommending this--they've been wrong.

specialty stores

A healthcare stock that pays a decent dividend is a popular hiding place, but this trade got really crowded. CVS got into a down channel. Wait until everybody has sold till you start buying. He's worried that investors are still buying and
analysts are still recommending this--they've been wrong.

specialty stores
William Chin

Portfolio , Caldwell Investment ...

Price Price
$63.330
Owned Owned
Unknown

TOP PICK
CVS Health Corp(CVS-N) 

June 1, 2018

The stock has been sluggish as it awaits regulatory approval for the Aetna merger. But the company enjoys consistent earnings and strong cash flow. You pay less than 10x earnings. He likes it for its underlying, high-margin retail operation which anchors the overall company in the face of regulatory threats. There's room to grow.  (Analysts' price target: $86.81)

specialty stores

The stock has been sluggish as it awaits regulatory approval for the Aetna merger. But the company enjoys consistent earnings and strong cash flow. You pay less than 10x earnings. He likes it for its underlying, high-margin retail operation which anchors the overall company in the face of regulatory threats. There's room to grow.  (Analysts' price target: $86.81)

specialty stores
Bryden Teich

Portfolio , Avenue Investment Ma...

Price Price
$64.070
Owned Owned
Yes

Showing 1 to 15 of 179 entries

No Comments.


You must be logged in to comment.

Successfully Saved Company
Successfully Saved Company